SOX in the Boardroom: What the Sarbanes?Oxley Act Means to You

June 15, 2003
Penny Cass

BioPharm International, BioPharm International-06-01-2003, Volume 16, Issue 6

by Penny Cass, BioPharm International Stay current on the changes in corporate governance regulations ? whether your company is public or private, in the United States or elsewhere. As a capital-intensive industry, many of our third-party associations are going to require that biopharmaceutical companies comply with the new regulations to receive financing. The trend to regulate corporate governance activities hasn't ended ? more rules promulgated by more government entities should be anticipated.